A detailed history of Wellington Management Group LLP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 90,825 shares of TYRA stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,825
Previous 117,032 22.39%
Holding current value
$1.4 Million
Previous $1.87 Million 14.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.7 - $24.36 $437,656 - $638,402
-26,207 Reduced 22.39%
90,825 $2.14 Million
Q2 2024

Aug 13, 2024

BUY
$14.45 - $20.22 $220,275 - $308,233
15,244 Added 14.98%
117,032 $1.87 Million
Q1 2024

May 15, 2024

BUY
$11.61 - $20.0 $1.18 Million - $2.04 Million
101,788 New
101,788 $1.67 Million
Q4 2023

Feb 12, 2024

BUY
$11.01 - $14.95 $1.13 Million - $1.53 Million
102,436 New
102,436 $1.42 Million
Q3 2023

Nov 14, 2023

BUY
$13.15 - $16.08 $192,989 - $235,990
14,676 Added 18.48%
94,112 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$11.99 - $17.51 $57,839 - $84,468
-4,824 Reduced 5.73%
79,436 $1.35 Million
Q1 2023

May 12, 2023

BUY
$6.85 - $16.22 $41,819 - $99,023
6,105 Added 7.81%
84,260 $1.35 Million
Q4 2022

Feb 13, 2023

SELL
$5.68 - $8.81 $39,913 - $61,907
-7,027 Reduced 8.25%
78,155 $593,000
Q3 2022

Nov 14, 2022

BUY
$6.61 - $12.42 $200,401 - $376,549
30,318 Added 55.26%
85,182 $748,000
Q2 2022

Aug 15, 2022

SELL
$5.26 - $11.19 $1.03 Million - $2.2 Million
-196,358 Reduced 78.16%
54,864 $392,000
Q1 2022

May 16, 2022

SELL
$10.03 - $14.09 $3.4 Million - $4.77 Million
-338,563 Reduced 57.4%
251,222 $2.69 Million
Q4 2021

Feb 11, 2022

SELL
$12.23 - $31.35 $1.29 Million - $3.31 Million
-105,586 Reduced 15.18%
589,785 $8.3 Million
Q3 2021

Nov 15, 2021

BUY
$16.91 - $26.0 $11.8 Million - $18.1 Million
695,371 New
695,371 $12.2 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $646M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.